Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
COVAC-2
BIOLOGICAL
3 trials
Sponsors
University of Saskatchewan
Conditions
Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
Double Vaccinated for COVID-19 (For Phase 1 of the Study)
Severe Acute Respiratory Syndrome Coronavirus 2
Phase 1
A Clinical Trial of COVAC-2 in Healthy Adults
Completed
NCT04702178
University of Saskatchewan
Severe Acute Respiratory Syndrome Coronavirus 2
Start: 2021-02-10
End: 2022-11-02
Updated: 2023-05-19
Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.
Completed
NCT05226702
University of Saskatchewan
Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group), Double Vaccinated for COVID-19 (For Phase 1 of the Study)
Start: 2022-07-22
End: 2023-11-13
Updated: 2024-05-03
Phase 2
A Clinical Trial of COVAC-2 in Adults
Completed
NCT05209009
University of Saskatchewan
Severe Acute Respiratory Syndrome Coronavirus 2
Start: 2022-08-24
End: 2024-03-01
Updated: 2024-05-02
Related Papers
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial
Figshare
2026-06-10
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial
Figshare
2026-06-10
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial.
2026-06-10